Cover Image
Read Now

Update on the SNG001 drug, an INFbeta therapy for COVID-19

Bibliographic Details
Main Author: Holgate, S. T.
Format: eBook
Language:English
Published: London Henry Stewart Talks 2020, 2020
Series:Research and clinical interviews
Subjects:
Interferon-beta / Administration & Dosage
Severe Acute Respiratory Syndrome Coronavirus 2
Pneumonia, Viral / Drug Therapy
Clinical Trials, Phase Ii As Topic
Pneumonia, Viral / Prevention & Control
Covid-19 (disease) / Prevention
Precision Medicine
Clinical Trials
Treatment Outcome
Coronavirus Infections / Drug Therapy
Covid-19 / Prevention & Control
Nebulizers And Vaporizers
Covid-19 (disease) / Treatment
Antiviral Agents / Development
Coronavirus Infections / Prevention & Control
Interferon
Antiviral Agents / Administration & Dosage
Interferon-beta / Therapeutic Use
Covid-19 / Drug Therapy
Coronavirus Infections / Chemotherapy
Online Access:
Collection: Henry Stewart Talks - Collection details see MPG.ReNa
Table of Contents:
  • An overview of SNG001 therapy
  • Findings of the phase 2 clinical trial
  • Treatment potential at different stages of the disease
  • Advantages of the treatment delivery mode and accessibility
  • Potential use as a prophylaxis treatment
  • Follow up clinical trials to be undertaken
  • Other treatment settings for INFβ

Similar Items